Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/02/2003WO2003011906A3 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
10/02/2003WO2003010199A3 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
10/02/2003WO2003010194A3 Meningococcus adhesins nada, app and orf 40
10/02/2003WO2003007793A3 Compositions, methods, and kits related to treating and diagnosing hypertension
10/02/2003WO2003006950A3 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2003004614A3 Identification and use of conserved noncoding sequences
10/02/2003WO2002099056A3 C22c7orfs as modifiers of the p53 pathway and methods of use
10/02/2003WO2002097040A3 Methods for the identification of inhibitors of pectin esterase expression or activity in plants
10/02/2003WO2002094949A3 Detection method for identifying hydrolases
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002090382A3 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
10/02/2003WO2002077274A3 Methods for purifying and detecting double stranded dna target sequences by triple helix interaction
10/02/2003WO2002072882A3 Coronary chip
10/02/2003WO2002072879A3 Production and use of random arrangements of clonal nuclear acid islands on a surface
10/02/2003WO2002070737A9 Compositions and methods relating to osteoarthritis
10/02/2003WO2002068679A3 Determining the risk of caries in a patient
10/02/2003WO2002068597A3 Enzymes having alpha amylase activity and methods of use thereof
10/02/2003WO2002064822A3 Method and kit for animal species-specific dna identification of a sample
10/02/2003WO2002063037A3 Method for identifying functional nucleic acids
10/02/2003WO2002059355A3 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/02/2003WO2002053771A3 Detection of pathogenic bacteria
10/02/2003WO2002044408A3 A method for identifying enzyme inhibitors
10/02/2003WO2002044403A3 Markers for testing analogs of vitamin d and therapeutical uses
10/02/2003WO2002042432A3 Epothilone resistant cell lines
10/02/2003WO2002038808A3 Slide or chip hybridisation unit
10/02/2003WO2002036819A9 BRCA1 AND hMLH1 GENE PRIMER SEQUENCES AND METHOD FOR TESTING
10/02/2003WO2002036818A3 Method for detecting inhibitors of tumour growth
10/02/2003WO2002029104A3 Tumor marker and methods of use
10/02/2003WO2002022875A3 Polymorphisms associated with cardiac arrythmia
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002020570A3 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
10/02/2003WO2002018641A3 Detection of cyp3a4 and cyp2c9 polymorphisms
10/02/2003WO2002014547A3 Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders
10/02/2003WO2002012551A3 Map-based genome mining method for identifying gene regulatory loci
10/02/2003WO2002006527A3 Method for detection of truncated proteins
10/02/2003WO2002004948A3 Distinguishing molecular forms
10/02/2003WO2002004677A3 Methods for diagnosis and treatment of psychiatric disorders
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001094615A3 Method for breeding and genotyping chickens and probes therefor
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001083814A3 Assay for nucleic acid analysis
10/02/2003US20030188347 Hybrid winter oilseed rape and methods for producing same
10/02/2003US20030188343 Identification of genes associated with growth in plants
10/02/2003US20030188342 Gene related to regeneration ability of plants and uses thereof
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030188326 Detecting cell proliferative disorders associated with breast, ovaries or prostate via monitoring mutation in gene associated with franconi anemia; antitumor/antiproliferative agents
10/02/2003US20030188325 Genetically engineered rodent cells comprising mutated regulatory erythroid kinase (REDK) gene for treatment of blood disorders such as anemia; animal models
10/02/2003US20030187593 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
10/02/2003US20030187591 Method of and apparatus for genomic analysis, and computer product
10/02/2003US20030187588 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby
10/02/2003US20030187579 Method for predicting the formation of mould fungi
10/02/2003US20030187335 Methods for determining whether subject is at risk of developing vascular disease associated with specific allele of polymorphic region of interleukin 1 receptor antagonist gene, based on detection of polymorphism within said gene
10/02/2003US20030187243 Novel expression-regulating sequences and expression products in the field of filamentous fungi
10/02/2003US20030187240 Nuclease resistant
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187237 Determining nucleotide sequences via sequential removal of nucleotides from one end of at least one nucleic acid, transporting through a channel and identifying nucleotide by raman spectroscopy
10/02/2003US20030187056 Enzyme inhibitors; rolipram; antiinflammatory agents, bone disorders, respiratory system disorders, skin disorders
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
10/02/2003US20030186911 Inhibition of infectious agents by exogenous oligonucleotides
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186871 Contacting a solution comprising an AKR1C polypeptide or fragment with agent, selecting an agent that modulates the expression or catalytic activity of AKR1C polypeptide or fragmet, thereby identifying an agent for therapy of diabetes
10/02/2003US20030186861 HAUSP-p53 interaction and uses thereof
10/02/2003US20030186850 Administering an effective amount of an appropriate agent which is effective in modulating functions of one or more polypeptide GalNAc-transferases (N-acetylgalactosaminyltransferases)
10/02/2003US20030186837 Contacting Asparagine Synthase polypeptide with test compound; detecting presence or absence of binding between test compound and Asparagine Synthase polypeptide, wherein binding indicates that test compound is candidate for antibiotic
10/02/2003US20030186458 Apparatus and methods for chemiluminescent assays
10/02/2003US20030186438 Premature osteoblast cell line derived from the peritoneum of bone for use as models for prevention and treatment of osteoporosis
10/02/2003US20030186428 Preparing a sample to be analyzed from a sample with very large volume
10/02/2003US20030186427 Apparatus for selectively converting photogenerated reagent precursors to photogenerated reagents associated with parallel synthesis of molecular sequence arrays on solid surfaces
10/02/2003US20030186425 Muscodor culture for use in generation of fungicidal, bactericidal, insecticidal and nematocidal compositions for biological pest control
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186423 Amidase from variovorax
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186385 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186374 Multimeric polypeptide plasmid for expression of complex heterologous proteins
10/02/2003US20030186370 Comprises nucleotide sequences coding nicotinic-acetylcholine receptor (5-ht3) for use in screening nematocides, insecticides and/or pesticides
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186359 Genes encoding insect odorant receptors and uses thereof
10/02/2003US20030186358 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186356 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/02/2003US20030186355 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
10/02/2003US20030186351 Monitoring bacterial sensitivity to drugs via detection of dissolved oxygen concentration in fluids
10/02/2003US20030186350 Apparatus for use in the automated antibiotic susceptibility testing of samples, such as those from patients possibly infected by a microorganism
10/02/2003US20030186349 Optical molecular sensors for cytochrome P450 activity
10/02/2003US20030186348 Fluorescent detection method and reagent
10/02/2003US20030186347 Monitoring NAD(P)H dependent oxidoreductase activity for use in design of new catalytic specificities and drug screening; bioremediation; biosensing
10/02/2003US20030186346 Process for producing protein decomposition product
10/02/2003US20030186345 Macromolecular enzyme substrates
10/02/2003US20030186341 Determining and/or predicting toxicity and/or biologic effects of chemical compound on three to eleven distinct microorganism immobilized on microarray; in vitro biochemical fingerprinting of bacteria
10/02/2003US20030186339 Individualization of therapy with antibiotic agents
1 ... 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 ... 3003